$46.44
Revolution Medicines is a biotechnology business based in the US. Revolution Medicines shares (RVMD) are listed on the NASDAQ and all prices are listed in US Dollars. Revolution Medicines employs 411 staff and has a trailing 12-month revenue of around $4.6 million.
Our top picks for where to buy Revolution Medicines stock
How to buy Revolution Medicines stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – RVMD. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Revolution Medicines stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Revolution Medicines stock price (NASDAQ: RVMD)
Use our graph to track the performance of RVMD stocks over time.Revolution Medicines shares at a glance
Latest market close | $45.56 |
---|---|
52-week range | $15.44 - $48.61 |
50-day moving average | $39.83 |
200-day moving average | $31.23 |
Wall St. target price | $59.69 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-3.84 |
Is it a good time to buy Revolution Medicines stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Revolution Medicines price performance over time
Historical closes compared with the close of $45.56 from 2024-07-25
1 week (2024-07-19) | -1.26% |
---|---|
1 month (2024-06-27) | 18.25% |
3 months (2024-04-26) | 26.70% |
6 months (2024-01-26) | 64.18% |
1 year (2023-07-27) | 81.01% |
---|---|
2 years (2022-07-27) | 88.26% |
3 years (2021-07-27) | 62.60% |
5 years (2019-07-23) | N/A |
Revolution Medicines financials
Revenue TTM | $4.6 million |
---|---|
Gross profit TTM | $-217,693,000 |
Return on assets TTM | -22.11% |
Return on equity TTM | -36.17% |
Profit margin | 0% |
Book value | $10.46 |
Market Capitalization | $7.6 billion |
TTM: trailing 12 months
Revolution Medicines share dividends
We're not expecting Revolution Medicines to pay a dividend over the next 12 months.
Revolution Medicines share price volatility
Over the last 12 months, Revolution Medicines's shares have ranged in value from as little as $15.44 up to $48.61. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Revolution Medicines's is 1.441. This would suggest that Revolution Medicines's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Revolution Medicines overview
Revolution Medicines, Inc. , a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Frequently asked questions
What percentage of Revolution Medicines is owned by insiders or institutions?Currently 2.387% of Revolution Medicines shares are held by insiders and 98.917% by institutions. How many people work for Revolution Medicines?
Latest data suggests 411 work at Revolution Medicines. When does the fiscal year end for Revolution Medicines?
Revolution Medicines's fiscal year ends in December. Where is Revolution Medicines based?
Revolution Medicines's address is: 700 Saginaw Drive, Redwood City, CA, United States, 94063 What is Revolution Medicines's ISIN number?
Revolution Medicines's international securities identification number is: US76155X1000 What is Revolution Medicines's CUSIP number?
Revolution Medicines's Committee on Uniform Securities Identification Procedures number is: 76155X100
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question